INTRODUCTION
I n 46,XY individuals, normal differentiation of male external genitalia is dependent on androgen effects in the androgen receptor (AR) (1) . Adequate number and function of AR are needed in order to allow complete virilization of male genitalia.
Abnormal genital development can be determined by insufficient testosterone synthesis, inadequate testosterone conversion to dihydrotestosterone, or by decreased androgen action (2) . At the AR level, in addition to AR gene mutations, both reduced amounts of AR mRNA or post-receptor abnormal response may be identified, resulting in a clinical condition classified as androgen insensitivity (3, 4) . Hypospadias are the most common clinical presentation of androgen insensitivity, presented as a spectrum of undermasculinized external genitalia (5) .
The diagnosis of abnormal genitalia requires the knowledge of AR gene sequence and the recognition of AR gene expression. As a rule, gene expression is a tissue-specific phenomenon (6), in a way that it is important to standardize normal expected AR gene expression in each of the androgen-sensitive tissues.
Therefore, defining normal genital expression of the AR gene is key information to ensure precise diagnosis of 46,XY patients with abnormal external genitalia, including hypospadias or micropenises.
In this study, in order to establish normal reference values, we determined androgen receptor mRNA in peripheral blood mononuclear cells, and preputial skin and urethral mucosa cells of normal control individuals with phimosis, using quantitative RT-PCR.
PATIENTS AND METHODS
We studied 30 control individuals with phimosis grades I to III, and urethras with normotopic opening. Patients were in the prepubertal stage, with chronological age varying from 1.5 to 11.9 years. All individuals presented normotopic testes, with a testicular volume between 1 and 2 mL. The exclusion criteria were systemic or local treatment with steroids during the six months preceding surgery, and known gonadal dysgenesis or chromosomal abnormalities. The protocol was approved by the Ethics Committee of the institution, and parents or guardians signed a written consent form for patient inclusion in the study protocol.
Peripheral blood mononuclear cells, preputial skin and urethral mucosa were collected in order to obtain 
RESULTS
We studied 30 control individuals with phimosis, with chronological age varying from 1.5 to 11.9 years. Clinical features are described in table 1. Penis size correlated significantly with age (R = 0.66, p = 0.02).
Quantitative results of AR mRNA are described in relation to the amount of constitutive gene BCR, and presented as AR/BCR ratio ( Table 2 and Figure 1 ). AR expression was similar when urethral mucosa was compared with preputial skin. The expression of the AR gene was significantly higher in both genital tissues (preputial skin and urethral mucosa) in comparison with the expression of peripheral blood mononuclear cells (Friedman ANOVA). There was no correlation between age or penis size and AR expression in the three analyzed tissues. 
DISCUSSION
External genital differentiation and development is dependent on androgen sensitivity, and it is related to the action of testosterone and/or dihydrotestosterone on the androgen receptor. Abnormal androgen sensitivity has been recognized in patients with genital anomalies, such as cryptorchidism, micropenis and hypospadia. In these conditions, mutations in the AR gene are not always detected, and a reduction in AR mRNA has been considered potentially involved. In order to confirm this reduction, it is essential to standardize normal values of ARmRNA in a tissue-specific manner. Direct quantitation of genital tissue ARmRNA is not available in the literature. In this study, the use of an absolute measurement of AR was possible by employing real time PCR. This method has proved to be reproducible and accurate, enabling AR measurement in the analyzed tissues.
Individuals with isolated phimosis, with no other genital anomaly, represented a control group. This group enabled the establishment of reference values for AR gene expression in peripheral blood mononuclear cells and cells from genital tissues. Our results demonstrated lower AR expression in peripheral blood mononuclear cells, when compared with the urethra and the prepuce. Therefore, ARmRNA determined in PBMC does not reflect the quantity of ARmRNA present in genital tissues, and should not be used in the diagnosis of genital anomalies. Specific target-tissue sample is nee ded to recognize the androgen action. Preputial skin is the most prominent tissue related to genital differentiation and development, but presents limited availability in patients who do not need surgery. In this study, we also measured ARmRNA from genital cells obtained by a simple swab of the urethral mucosa. Our results demonstrated that these cells presented AR expression comparable to that observed in preputial skin. Swabbing urethral mucosa is a feasible procedure to obtain a representative tissue sample, and seems to be an adequate alternative to genital skin.
We concluded that the method we employed for absolute quantitation of ARmRNA is reproducible and enabled precise determination of gene expression in several tissues, including samples from external genitalia. AR expression in peripheral blood mononuclear cells is low, and not representative of genital androgen sensitivity. We also concluded that cells sampled from the urethral mucosa may be used in place of genital skin in the determination of genital expression of ARmRNA. This method presents the potential to be employed in the investigation of several conditions in which there is a suspicion of abnormal quantitative AR gene expression, such as disorders of sexual differentiation, and in understanding phenotype/genotype variability in hyperandrogenic syndromes, such as congenital adrenal hyperplasia.
